Designation facilitates data sharing, promotes transparency and trust in clinical research
Public consultation open until end September 2025
Data collection is key in tackling antimicrobial resistance
CHMP recommends five new medicines for approval in the EU
Seizing opportunities in a changing medicines landscape
Patients invited to report suspicious offers
Find medicine
What's new
FAQs
Latest news
Designation facilitates data sharing, promotes transparency and trust in clinical research
Yearly updates to virus strains ensure vaccine effectiveness
Proposal aims to encourage development and improve patient access
Data comes from EU27 plus Iceland and Norway
Five new medicines recommended for approval; another seven medicines recommended for extension of their therapeutic indications
Benefits continue to outweigh risks, with new risk minimisation measures and more information to be provided about long-term effect on the heart